Clinical Trial Update: Evaluation of Target Organs Impairment on Patients Suffering From High Blood Pressure

View source ↗

Summary

An update on a completed AstraZeneca-sponsored trial evaluating target organ impairment in patients with hypertension. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: AstraZeneca | Conditions: Blood Pressure | Status: COMPLETED